Therefore, the CRP level represents no tumor marker, but an important biomarker for monitoring response to treatment of a cancer-related disease trait (tumor-related inflammation): A CRP decrease indicates the control of an either tumor-related or probably tumor-unrelated inflammatory process. The gene discussed is CRP; the disease is neoplasm.